GILD vs MGYR · P/E 18, rev $7.80B vs P/E 9.7, rev $44.8M
Gilead Sciences Inc (GILD) versus Magyar Bancorp Inc (MGYR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Magyar Bancorp Inc (MGYR) is a banks - regional company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported MGYR revenue for 2026-06-30 was $44.8M. Net income was $9.3M. Revenue was up 51.7% from 2026-03-31 to 2026-06-30. MGYR currently screens at market cap $111.2M and trailing P/E 9.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. MGYR currently screens at market cap $111.2M and trailing P/E 9.7.
Not investment advice. Open the GILD and MGYR stock pages for the full models.
Not investment advice.